Dna X (SONM) Invested Capital (2018 - 2025)
Historic Invested Capital for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$701000.0.
- Dna X's Invested Capital fell 10456.71% to -$701000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$701000.0, marking a year-over-year decrease of 10456.71%. This contributed to the annual value of -$5.7 million for FY2024, which is 12548.28% down from last year.
- Dna X's Invested Capital amounted to -$701000.0 in Q3 2025, which was down 10456.71% from -$1.3 million recorded in Q2 2025.
- Dna X's 5-year Invested Capital high stood at $23.1 million for Q3 2023, and its period low was -$5.7 million during Q4 2024.
- In the last 5 years, Dna X's Invested Capital had a median value of $17.5 million in 2024 and averaged $13.5 million.
- In the last 5 years, Dna X's Invested Capital surged by 20369.08% in 2023 and then tumbled by 12548.28% in 2024.
- Dna X's Invested Capital (Quarter) stood at $18.8 million in 2021, then rose by 7.53% to $20.2 million in 2022, then rose by 10.78% to $22.4 million in 2023, then crashed by 125.48% to -$5.7 million in 2024, then surged by 87.7% to -$701000.0 in 2025.
- Its last three reported values are -$701000.0 in Q3 2025, -$1.3 million for Q2 2025, and -$1.1 million during Q1 2025.